文献速递冠心病

4a型心肌梗死与围术期心肌损伤在非ST段抬高型心肌梗死患者中的预后意义

Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
PubMed 文献 · Circulation · 2025-02-19

该研究纳入1412例基线肌钙蛋白I稳定或下降的非ST段抬高型心肌梗死(NSTEMI)患者,按第四版心肌梗死通用定义分为4a型心肌梗死、无4a型心肌梗死的围术期心肌损伤(PMI)及无PMI三组。结果显示PMI与不良临床结局风险增加相关,4a型心肌梗死患者1年全因死亡率和主要不良心血管事件率最高,术后肌钙蛋白I变化>40%为预后相关PMI的最佳阈值。

要点

  • NSTEMI患者PCI术后PMI发生率高,4a型心肌梗死预后最差。
  • 术后肌钙蛋白I变化>40%且绝对值≥5倍99百分位上限为预后相关PMI最佳阈值。
  • 识别PMI有助于改善NSTEMI患者的风险分层和管理。

核心结论

  • NSTEMI患者PCI术后围术期缺血事件常见且具有预后意义。
  • 术后肌钙蛋白I变化>40%联合绝对值≥5倍99百分位上限是诊断预后相关PMI的最佳阈值。

研究设计与样本

  • 连续纳入2017年1月至2022年4月接受PCI且术前肌钙蛋白I稳定或下降的NSTEMI患者1412例。
  • 根据第四版心肌梗死通用定义分为4a型心肌梗死、无4a型心肌梗死的PMI及无PMI三组。
  • 主要终点为1年全因死亡率,次要终点为1年主要不良心血管事件。
  • 内部验证队列纳入2022年5月至2023年4月的305例患者。

主要发现

  • 240例(17%)发生4a型心肌梗死,288例(20.4%)发生无4a型心肌梗死的PMI,884例(62.6%)无PMI。
  • PMI与不良临床结局风险增加相关,4a型心肌梗死患者1年全因死亡率和主要不良心血管事件率最高。
  • 术后肌钙蛋白I变化>20%但≤40%的患者结局与无PMI患者相似,>40%为预后相关PMI的最佳阈值。
  • 内部验证队列305例证实了上述阈值。

关键数值与推荐

  • PMI定义:PCI术后48小时内肌钙蛋白I升高>20%且术后绝对值≥5倍99百分位参考上限。
  • 预后相关PMI最佳阈值:术后肌钙蛋白I变化>40%联合绝对值≥5倍99百分位参考上限。

临床怎么用

  • PCI术后应监测肌钙蛋白I变化,识别4a型心肌梗死和PMI以进行风险分层。
  • 术后肌钙蛋白I变化>40%且绝对值≥5倍99百分位上限提示预后相关PMI,需加强管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprocedural myocardial injury (PMI) with or without type 4a myocardial infarction (MI) might occur in patients with non-ST-segment-elevation MI (NSTEMI) after percutaneous coronary intervention (PCI). This study investigated the incidence and prognostic relevance of these events, according to current definitions, in patients with NSTEMI undergoing PCI. The best cardiac troponin I (cTnI) threshold of PMI for prognostic stratification is also suggested. METHODS: Consecutive patients with NSTEMI from January 2017 to April 2022 undergoing PCI with stable or falling pre-PCI cTnI levels were enrolled. According to the Fourth Universal Definition of Myocardial Infarction, the study population was stratified into those experiencing (1) PMI with type 4a MI, (2) PMI without type 4a MI, or (3) no PMI. Post-PCI cTnI increase >20% with an absolute postprocedural value of ≥5 times the 99th percentile upper reference limit within 48 hours after PCI was used to define PMI. The primary end point was 1-year all-cause mortality, and the secondary end point consisted of major adverse cardiovascular events at 1 year, including all-cause mortality, nonfatal reinfarction, urgent revascularization, nonfatal ischemic stroke, and hospitalization for heart failure. Internal validation was performed in patients enrolled between May 2022 and April 2023. RESULTS: Among 1412 patients with NSTEMI undergoing PCI with stable or falling cTnI levels at baseline, 240 (17%) experienced PMI with type 4a MI, 288 (20.4%) experienced PMI without type 4a MI, and 884 (62.6%) experienced no PMI. PMI was associated with an increased risk of adverse clinical outcomes, with patients with type 4a MI demonstrating the highest rates of 1-year all-cause mortality and major adverse cardiovascular events. A post-PCI ΔcTnI >20% but ≤40% showed similar outcomes to patients without PMI, whereas >40% was identified as the optimal threshold for prognostically relevant PMI, confirmed in an internal validation cohort of 305 patients. CONCLUSIONS: Periprocedural ischemic events were frequent in patients with NSTEMI undergoing PCI with prognostic implications. A post-PCI ΔcTnI >40%, combined with an absolute postprocedural value of ≥5 times the 99th percentile upper reference limit, was identified as the optimal threshold for diagnosing prognostically relevant PMI. Recognizing these events may improve risk stratification and management of patients with NSTEMI.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Armillotta, Bergamaschi, Paolisso, et al. Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction. Circulation. 2025. PMID: 39968630. doi:10.1161/CIRCULATIONAHA.124.070729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。